ALPHATEC HOLDINGS, INC. Deferred Revenue Recognized
ALPHATEC HOLDINGS, INC. (ATEC) reported Deferred Revenue Recognized of $7.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-02-24
- ALPHATEC HOLDINGS, INC. contract with customer, liability, revenue recognized for the quarter ending 2023-09-30 was $2.40M, a 29.41% decline year-over-year.
- ALPHATEC HOLDINGS, INC. contract with customer, liability, revenue recognized for the quarter ending 2023-06-30 was $3.00M, a 9.09% decline year-over-year.
- ALPHATEC HOLDINGS, INC. contract with customer, liability, revenue recognized for the quarter ending 2022-09-30 was $3.40M, a 29.17% decline year-over-year.
- ALPHATEC HOLDINGS, INC. contract with customer, liability, revenue recognized for the quarter ending 2022-06-30 was $3.30M, a 2.94% decline year-over-year.
- ALPHATEC HOLDINGS, INC. contract with customer, liability, revenue recognized for fiscal 2025 was $7.30M, a 47.10% decline from fiscal 2024.
- ALPHATEC HOLDINGS, INC. contract with customer, liability, revenue recognized for fiscal 2024 was $13.80M, a 26.61% increase from fiscal 2023.
- ALPHATEC HOLDINGS, INC. contract with customer, liability, revenue recognized for fiscal 2023 was $10.90M, a 15.50% decline from fiscal 2022.
- ALPHATEC HOLDINGS, INC. contract with customer, liability, revenue recognized for fiscal 2022 was $12.90M, a 11.64% decline from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized | Contract with Customer, Liability, Revenue Recognized as first filed | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 3 month as first filed | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 6 month as first filed | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 9 month as first filed | Contract with Customer, Liability, Revenue Recognized 12 month | Contract with Customer, Liability, Revenue Recognized 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $7.30M 10-K · filed 2026-02-24 | |||||||||
| 2024-12-31 | $13.80M 10-K · filed 2026-02-24 | |||||||||
| 2023-12-31 | $10.90M 10-K · filed 2026-02-24 | |||||||||
| 2023-09-30 | $2.40M 10-Q · filed 2023-11-06 | $9.30M 10-Q · filed 2023-11-06 | ||||||||
| 2023-06-30 | $3.00M 10-Q · filed 2023-08-03 | $7.00M 10-Q · filed 2023-08-03 | ||||||||
| 2023-01-01 | $4.20M 10-Q · filed 2023-05-04 | |||||||||
| 2022-12-31 | $12.90M 10-K · filed 2025-02-26 | |||||||||
| 2022-09-30 | $3.40M 10-Q · filed 2023-11-06 | $6.40M 10-Q · filed 2022-11-03 | $10.30M 10-Q · filed 2023-11-06 | $16.49M 10-Q · filed 2022-11-03 | ||||||
| 2022-06-30 | $3.30M 10-Q · filed 2023-08-03 | $5.80M 10-Q · filed 2022-08-04 | $6.90M 10-Q · filed 2023-08-03 | $10.13M 10-Q · filed 2022-08-04 | ||||||
| 2022-03-31 | $4.32M 10-Q · filed 2022-05-05 | |||||||||
| 2022-01-01 | $3.60M 10-Q · filed 2023-05-04 | $12.90M 10-K · filed 2023-02-28 | ||||||||
| 2021-12-31 | $14.60M 10-K · filed 2024-02-27 | $14.63M 10-K · filed 2022-03-02 | ||||||||
| 2021-09-30 | $4.80M 10-Q · filed 2022-11-03 | $8.20M 10-Q · filed 2022-11-03 | $8.17M 10-Q · filed 2021-11-04 | |||||||
| 2021-06-30 | $3.40M 10-Q · filed 2022-08-04 | $3.40M 10-Q · filed 2022-08-04 | $3.39M 10-Q · filed 2021-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |